felin
infecti
periton
fip
progress
highli
fatal
system
diseas
cat
caus
felin
coronaviru
felin
coronaviru
frequent
caus
inappar
enter
infect
fecal
shed
viru
mild
enter
diarrhea
seen
rare
see
chapter
mutat
felin
coronaviru
intestin
replic
enabl
infect
macrophag
caus
fip
despit
name
lesion
fip
widespread
restrict
peritoneum
effus
noneffus
form
fip
occur
sinc
recognit
fip
one
studi
diseas
cat
yet
definit
diagnost
test
effect
treatment
reliabl
vaccin
lack
declin
preval
felin
leukemia
viru
vaccin
fip
becom
deadliest
infecti
diseas
cat
felin
coronaviru
fcov
singlestrand
envelop
rna
viru
distinct
petalshap
peplom
project
surfac
two
serotyp
fcov
differ
cell
cultur
characterist
serotyp
predomin
north
america
europ
wherea
serotyp
ii
close
relat
canin
coronaviru
ccv
predomin
japan
coronavirus
found
mani
anim
gener
adapt
infect
epitheli
cell
respiratori
gastrointestin
tract
fcov
close
relat
ccv
swine
transmiss
gastroenter
viru
tgev
porcin
respiratori
viru
human
coronavirus
ccv
caus
enter
diarrhea
dog
see
chapter
infect
cat
caus
antibodi
crossreact
fcov
experiment
ccv
caus
enter
diarrhea
even
fip
cat
key
point
fipcaus
coronavirus
genet
mutant
harmless
enter
fcov
previous
thought
cat
infect
two
similar
distinct
coronavirus
innocu
felin
enter
coronaviru
deadli
fip
viru
consid
phenotyp
variant
biotyp
viru
nonmut
enterotrop
fcov
typic
caus
clinic
inappar
infect
intestin
epitheli
cell
fecal
shed
viru
replic
cat
intestin
tract
fcov
mutat
frequent
especi
kitten
sporad
result
critic
genet
mutat
enabl
fcov
infect
replic
macrophag
potenti
develop
fip
viru
mutat
replic
allow
mutat
fcov
variant
infect
macrophag
viral
replic
macrophag
defin
event
fip
macrophag
replic
mutat
coronaviru
carri
target
tissu
peritoneum
pleura
kidney
uvea
nervou
system
result
widespread
immunemedi
vascul
dissemin
perivascular
pyogranulomat
inflamm
exud
fibrin
polyseros
characterist
lesion
fip
pathogenesi
involv
circul
immun
complex
complement
fixat
cytokin
releas
apoptosi
activ
lymphocyt
vascular
damag
necrosi
increas
permeabl
key
point
viru
caus
widespread
damag
fip
diseas
consequ
cat
immun
reaction
viru
natur
immun
fcov
poorli
understood
presum
cell
mediat
rather
antibodi
mediat
circul
fcov
antibodi
actual
enhanc
progress
diseas
fcov
ubiquit
cat
worldwid
mani
region
cat
posit
coronavir
antibodi
ie
seropreval
major
seroposit
cat
repres
current
past
inappar
infect
nonmut
fcov
develop
mutat
fipcaus
infect
thu
preval
fip
much
lower
preval
fcov
infect
highest
cat
confin
crowd
group
catteri
shelter
multipl
cat
household
seropreval
rang
endem
catteri
seropreval
approach
fcovinfect
cat
remain
healthi
develop
fip
seropreval
fcov
freeroam
feral
stray
cat
lower
preval
presum
relat
less
social
interact
less
exposur
fecal
excret
viru
catteri
cat
seropreval
singlecat
household
less
larg
survey
north
american
veterinari
teach
hospit
fip
diagnos
everi
new
felin
access
popul
mostli
repres
sick
cat
seen
veterinarian
fcov
infect
wild
felid
includ
lion
cougar
cheetah
jaguar
leopard
bobcat
sand
cat
carac
serval
lynx
cheetah
especi
suscept
develop
fip
key
point
whenev
fcov
exist
cat
potenti
develop
fip
fcov
infect
occur
often
young
kitten
matern
antibodi
dissip
week
age
thu
infect
rate
highest
catteri
kitten
rais
associ
virusexcret
adult
cat
young
cat
increas
risk
develop
fip
peak
incid
fip
month
year
age
although
cat
age
affect
crowd
group
confin
multicat
household
purebr
catteri
shelter
increas
risk
factor
intrins
shelter
experi
increas
fecal
shed
fcov
millionfold
week
key
point
cat
fip
come
catteri
shelter
factor
increas
fcov
replic
intestin
infect
cat
increas
probabl
viru
mutat
form
caus
fip
thu
viral
load
stress
immun
impair
corticosteroid
surgeri
concurr
diseas
eg
felin
leukemia
viru
felin
immunodefici
viru
risk
factor
fip
inherit
genet
suscept
fip
factor
purebr
cat
cheetah
fcov
primarili
excret
fece
cat
inappar
enter
infect
healthi
carrier
often
shed
fcov
fece
least
month
cat
shed
persist
mani
year
possibl
life
onethird
healthi
fcovseroposit
cat
activ
shed
viru
highdens
endem
catteri
healthi
cat
may
shed
viru
given
time
fcov
usual
inactiv
hour
room
temperatur
viru
surviv
week
dri
fecal
debri
thu
environment
contamin
small
particl
use
litter
import
sourc
infect
contamin
surfac
food
water
dish
human
cloth
shoe
hand
act
fomit
disinfect
deterg
easili
destroy
fcov
transmiss
uninfect
cat
frequent
occur
oronas
contact
viruscontain
fece
contamin
materi
environ
contamin
litter
dust
particl
deposit
fur
ingest
normal
groom
activ
key
point
indoor
confin
crowd
group
increas
exposur
larg
dose
infecti
viru
fece
share
litter
box
catteri
kitten
frequent
infect
lose
maternalderiv
immun
week
age
contact
fece
virusshed
adult
cat
remov
kitten
contact
adult
cat
week
age
prevent
infect
see
prevent
fcov
also
excret
saliva
respiratori
secret
urin
unlik
import
sourc
infect
transplacent
transmiss
possibl
uncommon
cat
fip
shed
mostli
avirul
nonmut
fcov
virul
mutat
viru
caus
fip
thu
fip
directli
contagi
cat
fip
also
excret
less
fcov
healthi
carrier
greatest
risk
develop
fip
within
first
month
initi
infect
fcov
encompass
unpredict
often
prolong
period
time
take
carrier
harmless
nonmut
fcov
develop
critic
viral
mutat
time
take
mutat
viru
produc
clinic
diseas
onset
clinic
sign
often
insidi
occasion
sudden
especi
young
kitten
key
point
chronic
fluctuat
fever
unrespons
antibiot
frequent
earli
sign
fip
viral
dissemin
occur
clinic
ill
develop
fip
virtual
alway
progress
fatal
howev
consider
variat
durat
clinic
ill
death
week
typic
prolong
ill
exceed
month
occur
intermitt
ill
punctuat
period
remiss
effus
fip
clinic
cours
usual
acut
day
week
noneffus
fip
cours
often
chronic
insidi
week
month
cat
ocular
involv
sometim
surviv
year
key
point
cat
effus
wet
form
fip
predomin
locat
inflammatori
fluid
abdomin
caviti
thorac
caviti
caviti
effus
fip
involv
periton
caviti
caus
progress
nonpain
fluid
distens
abdomen
effus
detect
palpat
percuss
fluid
wave
earli
stage
small
amount
abdomin
fluid
may
detect
palpat
intestin
loop
feel
excess
slipperi
though
seros
surfac
highli
lubric
pain
palpat
infrequ
extens
periton
inflamm
may
involv
gastrointestin
tract
vomit
diarrhea
hepatobiliari
system
jaundic
pancrea
vomit
due
pancreat
scrotal
swell
may
occur
intact
male
direct
extens
periton
inflamm
effus
testicular
tunic
adhes
may
organ
mesenteri
omentum
viscera
irregular
firm
mass
palpabl
cranioventr
abdomen
cat
nonmut
fcov
infect
intestin
tract
infrequ
develop
clinic
sign
see
chapter
section
describ
clinic
manifest
mutat
fipproduc
fcov
infect
cat
fip
often
present
initi
nonspecif
nonloc
sign
fever
anorexia
inact
weight
loss
vomit
diarrhea
dehydr
pallor
anemia
diseas
progress
sign
worsen
addit
clinic
sign
develop
indic
either
bodi
caviti
effus
wet
form
diseas
organspecif
abnorm
noneffus
dri
form
tabl
approxim
effus
noneffus
cat
manifest
featur
effus
noneffus
diseas
chang
time
one
form
natur
incub
period
extrem
variabl
rang
week
sever
year
cat
surfac
infiltr
throughout
renal
cortex
extens
renal
involv
occasion
caus
renal
failur
polyuriapolydipsia
azotemia
increas
blood
urea
nitrogen
bun
serum
creatinin
proteinuria
frequent
laboratori
find
renal
fip
addit
larg
quantiti
circul
immun
complex
may
lead
subclin
glomerulonephr
form
effus
noneffus
fip
pyogranulomat
hepat
hepatomegali
jaundic
sign
hepat
failur
may
occur
fip
consist
laboratori
abnorm
bilirubinuria
hyperbilirubinemia
mild
moder
elev
serum
liver
enzym
alanin
aminotransferas
alkalin
phosphatas
serum
bile
acid
also
may
occur
pyogranulomat
lesion
may
caus
palpabl
enlarg
viscer
lymph
node
spleen
omentum
pyogranulomat
enterocol
may
caus
diarrhea
diffus
masslik
intestin
thicken
especi
ileocecocolon
region
pancreat
involv
occasion
caus
pancreat
rare
diabet
mellitu
ocular
lesion
fip
usual
bilater
affect
vascular
tunic
uvea
uveiti
lesion
may
sometim
caus
blind
manifest
exud
anterior
uveiti
iridocycl
may
includ
miosi
aqueou
flare
kerat
fibrinocellular
precipit
hypopyon
muttonfat
deposit
cell
fibrin
hyphema
anterior
chamber
adhes
synechia
corneal
edema
deep
neovascular
cornea
see
chapter
chorioretin
posterior
uveal
involv
detect
ophthalmoscop
examin
may
includ
perivascular
cuf
exud
retin
detach
retin
hemorrhag
see
chapter
multifoc
pyogranulomat
meningoenceph
myeliti
frequent
fip
inflammatori
lesion
perivascular
often
involv
mening
ependym
layer
one
report
cat
fip
develop
neurolog
sign
retrospect
survey
cat
neurolog
diseas
lesion
indic
fip
cn
found
anoth
larg
abdomin
effus
confirm
radiographi
ultrasonographi
abdominocentesi
result
fluid
analysi
highli
indic
fip
see
diagnosi
dyspnea
tachypnea
exercis
intoler
major
present
sign
lung
expans
restrict
compress
fluid
pleural
space
cat
pleural
effus
may
prefer
sit
sternal
recumb
postur
facilit
breath
increas
respiratori
distress
may
occur
exercis
physic
restraint
hospit
reposit
later
recumb
ie
orthopnea
thorac
effus
may
caus
muffl
heart
lung
sound
auscult
hyporeson
horizont
fluid
line
thorac
percuss
thorac
effus
confirm
radiographi
thoracocentesi
see
chapter
result
fluid
analysi
highli
indic
fip
see
diagnosi
pericardi
effus
due
fibrin
pericard
may
occur
fip
without
effus
one
survey
fip
second
frequent
caus
felin
pericardi
effus
account
case
pericardi
effus
fip
usual
caus
overt
clinic
sign
may
suspect
auscult
muffl
heart
sound
thorac
radiographi
electrocardiographi
confirm
echocardiographi
see
chapter
key
point
noneffus
dri
form
fip
character
multifoc
pyogranulomat
inflamm
necrot
vascul
variou
organ
abdomin
viscera
eg
liver
spleen
kidney
pancrea
intestin
eye
central
nervou
system
cn
lung
pyogranuloma
appear
multipl
discreet
coalesc
graywhit
nodular
mass
variabl
size
surfac
within
parenchyma
affect
organ
often
mistaken
tumor
effus
often
minim
absent
specif
organ
affect
degre
result
organ
failur
determin
present
clinic
sign
pyogranulomat
nephriti
caus
kidney
becom
palpabl
enlarg
firm
irregular
lumpi
associ
pyogranuloma
scatter
survey
fip
common
spinal
diseas
cat
neuroanatom
distribut
lesion
determin
clinic
sign
common
ataxia
tremor
vestibular
dysfunct
seizur
posterior
paresi
hyperesthesia
behavior
chang
relentless
progress
multifoc
natur
sign
characterist
featur
neural
fip
neuropathi
occasion
involv
cranial
nerv
eg
trigemin
facial
peripher
nerv
eg
brachial
sciatic
cat
neural
fip
often
develop
secondari
hydrocephalu
inflammatori
process
obstruct
flow
cerebrospin
fluid
csf
one
studi
cat
neural
fip
hydrocephalu
dilat
ventricular
central
canal
system
identifi
comput
tomographi
ct
magnet
reson
imag
mri
scan
mening
enhanc
also
seen
mri
diagnosi
neural
fip
depend
csf
analysi
see
section
diagnosi
pyogranulomat
pneumonia
found
cat
fip
thorac
radiograph
necropsi
case
clinic
silent
caus
mild
cough
appear
radiograph
diffus
poorli
defin
patchi
nodular
interstiti
pulmonari
infiltr
testicular
enlarg
caus
pyogranulomat
orchiti
report
fip
contrari
specul
past
fcov
directli
associ
catteri
reproduct
problem
neonat
death
birth
weak
fade
kitten
nonmut
fcov
infect
character
persist
viral
replic
enterocyt
fecal
shed
viru
activ
fecal
shed
fcov
confirm
revers
transcript
polymeras
chain
reaction
rtpcr
assay
fece
see
later
section
rtpcr
assay
electron
microscopi
fece
fals
neg
occur
diagnost
techniqu
quantiti
fecal
viru
fluctuat
ideal
fece
check
daili
consecut
day
determin
cat
nonshedd
intestin
biopsi
intestin
biopsi
show
nonspecif
lesion
villou
tip
injuri
stunt
fusion
villi
immunofluoresc
immunohistochem
stain
viral
antigen
intestin
biopsi
confirmatori
diagnosi
fip
usual
suspect
clinic
sign
result
routin
laboratori
evalu
see
tabl
singl
reliabl
confirmatori
test
fip
thu
base
clinic
diagnosi
fip
combin
result
wellchosen
laboratori
evalu
eg
hematolog
serum
chemistri
cytolog
serolog
virolog
diagnost
imag
histopatholog
tabl
key
point
clinic
sign
laboratori
abnorm
cat
fip
specif
diseas
howev
collect
may
provid
strong
circumstanti
evid
presumpt
diagnosi
fip
hematolog
often
reveal
nonspecif
abnorm
reflect
chronic
inflammatori
respons
nonregen
anemia
neutrophil
leukocytosi
leukopenia
stress
lymphopenia
total
serum
protein
serum
globulin
especi
gamma
alpha
increas
chronic
immun
stimul
noneffus
case
effus
case
wherea
serum
albumin
often
decreas
one
studi
show
decreas
serum
albumintoglobulin
ratio
ag
indic
high
probabl
fip
posit
predict
valu
ag
suggest
fip
unlik
neg
predict
valu
serum
protein
electrophoresi
usual
necessari
serum
chemistri
may
detect
involv
abdomin
organ
liver
increas
serum
liver
enzym
bilirubin
bile
acid
kidney
increas
creatinin
bun
pancrea
increas
pancreat
lipas
immunoreact
urinalysi
find
may
includ
proteinuria
bilirubinuria
dissemin
intravascular
coagul
sometim
develop
fip
result
prolong
coagul
time
decreas
platelet
increas
fibrin
degrad
product
see
chapter
diagnost
imag
use
identifi
organ
site
involv
fip
imag
also
facilit
procur
diagnost
fluid
biopsi
specimen
radiographi
use
confirm
abdomin
thorac
effus
abdomin
organ
enlarg
eg
kidney
liver
pulmonari
infiltr
affect
abdomin
organ
liver
kidney
spleen
pancrea
intestin
omentum
lymph
node
also
imag
aspir
biopsi
use
ultrasonographi
cat
neurolog
fip
secondari
obstruct
hydrocephalu
common
find
ct
mri
scan
contrast
enhanc
mening
ependyma
also
may
seen
mri
key
point
fluid
analysi
usual
suffici
clinic
diagnosi
effus
fip
typic
fluid
effus
fip
highli
proteinac
pyogranulomat
exud
fip
fluid
appear
clear
viscou
straw
yellow
golden
may
tenaci
sticki
contain
fleck
strand
fibrin
fluid
get
frothi
shaken
high
protein
concentr
may
clot
refriger
fip
fluid
high
protein
concentr
approach
plasma
rang
gdl
effus
fip
highli
like
total
fluid
protein
gdl
globulin
portion
greater
ag
usual
less
gamma
globulin
percentag
greater
fluid
protein
electrophoresi
also
highli
indic
fip
ag
ratio
greater
albumin
percentag
greater
indic
diseas
fip
highli
like
fip
fluid
usual
nucleat
cell
count
rang
cellsml
low
compar
exud
cytolog
pattern
fip
fluid
pyogranulomat
exud
predomin
cell
wellpreserv
nondegener
neutrophil
macrophag
variabl
number
plasma
cell
lymphocyt
addit
evalu
effus
includ
assay
antifcov
antibodi
see
coronavir
antibodi
test
rtpcr
assay
detect
coronavir
nucleic
acid
see
later
section
pcr
assay
antibodi
rtpcr
assay
effus
may
higher
diagnost
valu
serum
test
fcov
antigen
use
either
immunofluoresc
immunohistochemistri
definit
confirmatori
test
effus
fip
posit
predict
valu
see
immunofluoresc
immunohistochemistri
anterior
chamber
eye
ocular
fip
high
diagnost
valu
protein
concentr
nucleat
cell
count
neutrophil
macrophag
lymphocyt
increas
csf
cat
neural
fip
see
tabl
aqueou
humor
cat
intraocular
fip
csf
anterior
chamber
fluid
also
evalu
presenc
antifcov
antibodi
see
follow
section
fip
ratio
csf
ocular
antibodi
serum
antibodi
gener
much
higher
ratio
csf
ocular
total
protein
serum
total
protein
pcr
assay
csf
anterior
chamber
fluid
coronavir
nucleic
acid
use
see
section
pcr
assay
combin
progress
neurolog
sign
especi
multifoc
increas
csf
protein
leukocyt
especi
neutrophil
hydrocephalu
imag
test
coronavir
serum
antibodi
inform
epidemiolog
screen
tool
diagnost
aid
fcov
fip
reliabl
laboratori
use
result
interpret
properli
key
point
posit
coronavir
antibodi
test
mean
cat
expos
coronaviru
time
serolog
provid
definit
diagnosi
fip
antibodi
cat
infect
harmless
nonmut
fcov
distinguish
antibodi
cat
fip
larg
percentag
healthi
cat
popul
seroposit
fcov
antibodi
cat
never
develop
fip
addit
seroposit
distinguish
activ
past
infect
antibodi
relat
nonfcov
eg
ccv
tgev
crossreact
fcov
antibodi
lower
specif
seroconvers
initi
exposur
fcov
take
week
confirm
diagnosi
fip
absenc
fcov
antibodi
rule
diagnosi
fip
mani
commerci
diagnost
lab
measur
fcovantibodi
titer
howev
methodolog
variabl
thu
result
compar
lab
exampl
whether
felin
nonfelin
viral
antigen
use
test
procedur
influenc
titer
valu
indic
lowest
highest
titer
level
use
reliabl
commerci
diagnost
laboratori
measur
quantit
fcovantibodi
titer
level
avoid
use
rapid
inoffic
enzymelink
immunosorb
assay
elisa
test
mere
report
posit
neg
result
without
titer
quantificationthi
less
use
titer
inform
test
give
less
consist
result
convent
serolog
test
commerci
avail
elisa
test
detect
antibodi
gene
market
fipspecif
test
howev
mutat
gene
specif
fip
test
advantag
convent
serolog
assay
serum
plasma
sampl
fcov
antibodi
test
refriger
store
without
affect
test
fcov
antibodi
also
measur
effus
csf
anterior
chamber
fluid
aqueou
studi
suggest
diagnost
use
serum
test
similar
interpret
pitfal
healthi
cat
height
antibodi
titer
correl
viru
replic
rate
intestin
likelihood
fecal
shed
amount
viru
shed
fece
gener
low
titer
least
diagnost
valu
highest
measur
titer
level
assay
use
lab
highli
suggest
fip
still
confirmatori
one
studi
found
probabl
fip
highest
titer
level
rise
antibodi
titer
help
seen
healthi
cat
nonmut
fcov
titer
fluctuat
unpredict
fip
avirul
infect
healthi
carrier
nonmut
fcov
live
endem
catteri
multicat
environ
tend
higher
titer
individu
pet
cat
thu
high
titer
might
less
meaning
catteri
cat
less
catteri
cat
titer
ever
develop
fip
key
point
healthi
cat
neg
antibodi
like
free
fcov
thu
shed
viru
infecti
cat
risk
fip
falseneg
test
result
infrequ
occur
confirm
fip
case
thu
neg
titer
entir
rule
fip
falseneg
titer
result
low
antibodi
level
seen
peracut
infect
less
day
exposur
termin
stage
infect
consumpt
antibodi
immun
complex
laboratori
error
insensit
assay
system
also
explain
fals
neg
evalu
fcov
antibodi
effus
found
good
predict
valu
fip
posit
neg
suggest
fluid
test
may
diagnost
use
serum
test
key
point
interpret
rtpcr
test
clinic
find
use
sole
basi
diagnosi
fip
rtpcr
viral
assay
use
detect
coronavir
nucleic
acid
blood
fluid
tissu
fece
posit
result
indic
presenc
fcov
distinguish
mutat
fipproduc
variant
nonmut
fcov
viremia
occur
fip
also
healthi
fcov
carrier
one
studi
found
cat
endem
catteri
virem
rtpcrposit
predict
fip
thu
rtpcr
reliabl
confirmatori
diagnost
test
key
point
pcr
assay
distinguish
mutat
nonmut
fcov
gener
effus
tissu
specimen
like
blood
posit
cat
fip
plasma
sensit
serum
lowest
yield
csf
urin
recommend
routin
pcr
test
fecal
rtpcr
use
document
fecal
shed
fcov
especi
healthi
cat
compon
catteri
control
program
evalu
fece
daili
consecut
day
retest
sever
month
requir
identifi
chronic
persist
shedder
falseneg
rtpcr
result
degrad
sampl
rna
poor
laboratori
techniqu
primer
use
also
may
detect
strain
fcov
sampl
pcr
requir
care
handl
avoid
invalid
result
keep
sampl
frozen
assay
soon
possibl
optim
result
histopatholog
consid
gold
standard
confirm
fip
thu
biopsi
affect
tissu
valuabl
diagnost
procedur
identifi
distinct
fip
lesion
vascul
pyogranulomat
inflamm
coronaviru
identifi
tissu
specimen
pcr
immunofluoresc
antibodi
immunohistochemistri
techniqu
see
next
section
stain
macrophag
tissu
specimen
effus
intracellular
fcov
antigen
use
either
immunofluoresc
immunohistochemistri
definit
confirmatori
test
effus
fip
posit
predict
valu
ie
virtual
fals
posit
rule
fip
test
neg
fals
neg
occur
frequent
insuffici
infect
macrophag
specimen
viral
antigen
mask
competit
bind
fcov
antibodi
key
point
treatment
prove
reduc
risk
develop
fip
healthi
antibodyposit
fcov
carrier
treatment
prove
lower
high
mortal
rate
fip
slow
progress
diseas
variou
antivir
immunomodul
immunosuppress
drug
use
treat
fip
efficaci
highli
question
cat
show
temporari
improv
clinic
sign
support
care
antiinflammatori
therapi
use
corticosteroid
best
candid
palli
medic
therapi
cat
eat
activ
good
bodi
condit
spontan
remiss
occur
extrem
rare
euthanasia
appropri
sever
affect
cat
poor
qualiti
life
key
point
nearli
cat
confirm
clinic
fip
eventu
die
regardless
treatment
antivir
drug
eg
acyclovir
zidovudin
azt
activ
fcov
antivir
drug
eg
ribavirin
show
vitro
activ
fcov
either
toxic
cat
ineffect
use
clinic
treat
fip
ribavirintr
kitten
exampl
sever
clinic
sign
shorten
surviv
time
compar
untreat
kitten
ribavirin
also
caus
seriou
side
effect
hemolysi
bone
marrow
toxic
liver
toxic
cat
interferon
high
dose
immunomodul
antivir
activ
see
new
anticoronavir
drug
develop
treatment
human
sever
acut
respiratori
syndrom
coronaviru
might
futur
applic
cat
immunomodul
intend
stimul
compromis
immun
function
anecdot
report
clinic
improv
agent
substanti
control
studi
thu
conclus
evid
efficaci
fip
lack
nonspecif
immun
stimul
theoret
potenti
immunemedi
consequ
fip
immunomodul
agent
use
unsuccess
treat
fip
includ
propionibacterium
acn
immunoregulin
thioprolin
promodulin
acemannan
carrisyn
levamisol
cyclosporin
human
felin
interferon
use
treat
fip
see
recombin
form
interferon
given
parenter
high
dose
antivir
immunomodulatori
effect
felin
interferonomega
human
interferonalpha
use
treat
fip
recombin
felin
interferonomega
rfeifnw
avail
europ
japan
treat
fip
rfeifnw
virbagen
omega
virbac
given
ukg
sc
everi
day
clinic
remiss
twice
weekli
expens
prohibit
mani
owner
preliminari
uncontrol
studi
fip
cat
use
rfeifnw
prednison
mgkg
po
taper
mgkg
cat
achiev
complet
remiss
year
achiev
partial
remiss
die
month
fail
respond
die
parenter
highdos
human
interferonalpha
rhuifna
ukg
im
appear
effect
fip
unsuit
longterm
treatment
cat
develop
antibodi
human
protein
week
inhibit
drug
activ
oral
lowdos
human
interferonalpha
roferon
hoffmanlaroch
introna
scheringplough
dilut
uml
given
unit
po
daili
day
altern
week
reportedli
improv
appetit
wellb
minim
side
effect
rhuifna
given
oral
destroy
gastric
acid
achiev
system
level
may
exert
immunomodul
activ
oropharyng
lymphoid
tissu
lead
cytokin
releas
cat
transient
improv
support
care
combin
palli
medic
therapi
use
high
dose
corticosteroid
without
cytotox
alkyl
agent
chlorambucil
cyclophosphamid
tabl
corticosteroid
alkyl
drug
effect
viru
virtu
antiinflammatori
immunosuppress
effect
aim
control
widespread
immunemedi
inflammatori
reaction
occur
fip
drug
may
advers
affect
cellular
immun
mediat
lymphocyt
macrophag
thu
potenti
promot
viral
infect
key
point
use
immunosuppress
drug
treat
overt
fip
healthi
fcov
carrier
seroposit
cat
drug
could
unwant
effect
promot
onset
fip
princip
side
effect
alkyl
drug
anorexia
bone
marrow
suppress
thu
monitor
complet
blood
count
period
see
chapter
detail
use
drug
persist
druginduc
anorexia
frequent
problem
drug
given
daili
altern
puls
administr
use
larg
dose
drug
everi
week
way
day
dose
appetit
usual
rebound
maintain
treatment
cycl
regardless
regimen
chosen
respons
note
within
first
week
consid
therapi
ineffect
either
modifi
discontinu
posit
respons
occur
continu
treatment
indefinit
measur
may
improv
qualiti
life
possibl
surviv
time
minim
stress
exacerb
factor
perform
intermitt
bodi
caviti
drainag
effus
need
reliev
dyspnea
give
parenter
fluid
therapi
give
nutrit
support
via
tubefeed
techniqu
see
chapter
give
aspirin
mgkg
inhibit
platelet
aggreg
caus
vascul
give
antibiot
need
control
complic
bacteri
infect
treat
anterior
uveiti
topic
corticosteroid
atropin
see
chapter
give
blood
transfus
sever
nonregen
anemia
vaccin
viru
replic
local
nasopharynx
intestin
system
temperatur
sensit
suppos
stimul
local
nasal
gut
mucos
immun
salivari
immunoglobulin
antibodi
cellmedi
immun
protect
enter
fcov
infect
lack
proven
efficaci
kitten
younger
week
age
fundament
pitfal
circumst
kitten
first
becom
infect
fcov
week
age
report
american
associ
felin
praction
panel
felin
vaccin
state
time
evid
vaccin
induc
clinic
relev
protect
use
recommend
variou
genet
engin
recombin
vaccin
develop
may
becom
avail
futur
control
fcov
infect
catteri
shelter
multicat
household
aim
limit
viru
spread
minim
exposur
reduc
stress
infect
fcov
ubiquit
complet
erad
rare
feasibl
even
erad
success
reinfect
frequent
occur
test
remov
base
fcov
antibodi
test
practic
sinc
typic
cat
endem
catteri
seroposit
depopul
start
would
requir
key
point
consid
healthi
fcov
antibodyposit
cat
harmless
seroposit
cat
frequent
shed
fcov
fece
contamin
environ
infect
cat
fcov
alway
potenti
mutat
caus
fip
familiar
risk
factor
transmiss
fcov
see
epidemiolog
use
good
husbandri
practic
eg
good
sanit
ventil
feed
practic
limit
fecoor
contamin
minim
overcrowd
stress
highdens
hous
allow
high
level
fecal
contamin
environ
facilit
fecoor
spread
infect
control
felin
leukemia
viru
catteri
vaccin
test
remov
see
chapter
breed
male
femal
cat
histori
produc
kitten
later
develop
fip
potenti
may
pass
genet
suscept
fip
risk
infect
cat
show
breed
exchang
consid
low
howev
situat
allow
share
food
water
litter
allow
healthi
seroneg
cat
enter
coronavirusfre
catteri
ideal
cat
safe
mix
cat
confirm
absenc
fecal
shed
base
least
consecut
neg
fecal
rtpcr
test
although
may
practic
mani
situat
greatest
sourc
viral
contamin
environ
small
particl
fecal
debri
litter
carri
throughout
facil
movement
air
anim
peopl
contamin
materi
end
fur
thu
ingest
cat
consid
follow
control
measur
reduc
environment
viru
load
minim
exposur
use
least
one
litter
box
everi
two
cat
locat
litter
box
away
food
water
bowl
avoid
crosscontamin
ensur
area
easi
clean
disinfect
scoop
fece
litter
box
daili
replac
litter
disinfect
litter
box
often
possibl
least
weekli
dispos
use
litter
seal
plastic
bag
use
dedic
food
water
bowl
anim
clean
disinfect
bowl
regularli
brush
fur
cat
regularli
remov
contamin
fecal
particl
litter
could
ingest
groom
reduc
crosscontamin
cat
hous
cat
individu
stabl
small
group
four
less
avoid
mani
kitten
shed
greatest
amount
viru
ideal
identifi
elimin
persist
carrier
continu
shed
larg
amount
viru
use
fecal
rtpcr
test
repeat
sever
month
isol
earli
wean
effect
control
spread
fcov
kitten
well
herpesviru
caliciviru
